Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Vaxil Biotherapeutics Ltd patents

Recent patent applications related to Vaxil Biotherapeutics Ltd. Vaxil Biotherapeutics Ltd is listed as an Agent/Assignee. Note: Vaxil Biotherapeutics Ltd may have other listings under different names/spellings. We're not affiliated with Vaxil Biotherapeutics Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Vaxil Biotherapeutics Ltd-related inventors

Antigen specific multi epitope-based anti-infective vaccines

The invention provides peptide vaccines comprising the signal peptide domain of selected target antigens of intracellular pathogens. The peptide vaccines of the invention contain multiple class II and class I-restricted epitopes and are recognized and presented by the majority of the vaccinated human population. The invention provides in particular anti... Vaxil Biotherapeutics Ltd

Antigen specific multi epitope vaccines

The presently described subject matter relates to cancer vaccines composed of the signal peptide domain of tumor associated antigens or proteins. The described peptide vaccines have multiple MHC class I and class II epitopes which are highly abundant in the population. Therefore, these vaccines induce a strong, comprehensive immune response... Vaxil Biotherapeutics Ltd

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Vaxil Biotherapeutics Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vaxil Biotherapeutics Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by